- STAT+: White House offers its science blueprint: More AI, less life sciencesThe Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research dollars from universities to industry.STAT · 1d ago↗ source
- Gene editor Scribe starts second-half IPO spree with $129M listingA nine-year-old biotech co-founded by CRISPR pioneer Jennifer Doudna is kicking off a run of biotech IPOs set for this year's second half. Scribe Therapeutics priced its $128.7 millionEndpoints · 1d ago↗ source
- This Week at FDA: Diamantas touts onshoring efforts, grants for DHTs, and more<p>Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This…